1. Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015; 49:100–51. DOI:
10.1007/s12016-015-8509-4. PMID:
26445775.

2. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum. 2008; 59:952–60. DOI:
10.1002/art.23826. PMID:
18576290.

3. Wolfe F, Walitt B. Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol. 2013; 9:751–5. DOI:
10.1038/nrrheum.2013.96. PMID:
23820862.

4. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160–72. DOI:
10.1002/art.1780330203. PMID:
2306288.
5. Wolfe F. Editorial: the status of fibromyalgia criteria. Arthritis Rheumatol. 2015; 67:330–3. DOI:
10.1002/art.38908. PMID:
25303359.

6. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62:600–10. DOI:
10.1002/acr.20140. PMID:
20461783.

7. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011; 38:1113–22. DOI:
10.3899/jrheum.100594. PMID:
21285161.

8. Egloff N, von Känel R, Müller V, Egle UT, Kokinogenis G, Lederbogen S, et al. Implications of proposed fibromyalgia criteria across other functional pain syndromes. Scand J Rheumatol. 2015; 44:416–24. DOI:
10.3109/03009742.2015.1010103. PMID:
26079770.

9. Smythe HA. Unhelpful criteria sets for “diagnosis” and “assessment of severity” of fibromyalgia. J Rheumatol. 2011; 38:975–8. DOI:
10.3899/jrheum.110142. PMID:
21632687.

10. Friend R, Bennett RM. A critical examination of the polysymptomatic distress scale construct as a symptom severity questionnaire. J Rheumatol. 2015; 42:1364–7. DOI:
10.3899/jrheum.150611. PMID:
26233950.

11. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 2003; 48:1420–9. DOI:
10.1002/art.10893. PMID:
12746916.

12. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S154–62. PMID:
16273800.
13. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014; 66:1364–73. DOI:
10.1002/acr.22301. PMID:
24497443.

14. Ghavidel-Parsa B, Bidari A, Maafi AA, Hassankhani A, Hajiabbasi A, Montazeri A, et al. The impact of fibromyalgia on health status according to the types, demographic background and pain index. Clin Exp Rheumatol. 2016; 34(2 Suppl 96):S134–9. PMID:
27157398.
15. Bidari A, Ghav idel-Parsa B, Amir Maafi A, Montazeri A, Ghalehbaghi B, Hassankhani A, et al. Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population. Rheumatol Int. 2015; 35:2013–9. DOI:
10.1007/s00296-015-3340-z. PMID:
26581782.

16. Bidari A, Hassanzadeh M, Mohabat MF, Talachian E, Khoei EM. Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P). Rheumatol Int. 2014; 34:181–9. DOI:
10.1007/s00296-013-2883-0. PMID:
24166211.

17. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016; 46:319–29. DOI:
10.1016/j.semarthrit.2016.08.012. PMID:
27916278.

18. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011; 7:518–27. DOI:
10.1038/nrrheum.2011.98. PMID:
21769128.

19. Segura-Jiménez V, Álvarez-Gallardo IC, Carbonell-Baeza A, Aparicio VA, Ortega FB, Casimiro AJ, et al. Fibromyalgia has a larger impact on physical health than on psychological health, yet both are markedly affected: the al-Ándalus project. Semin Arthritis Rheum. 2015; 44:563–70. DOI:
10.1016/j.semarthrit.2014.09.010. PMID:
25440155.

20. Tastekin N, Uzunca K, Sut N, Birtane M, Mercimek OB. Discriminative value of tender points in fibromyalgia syndrome. Pain Med. 2010; 11:466–71. DOI:
10.1111/j.1526-4637.2009.00784.x. PMID:
20088857.

21. Friend R, Bennett RM. Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations. Arthritis Res Ther. 2011; 13:R58. DOI:
10.1186/ar3311. PMID:
21477308. PMCID:
3132053.

22. Silverman SL, Harnett J, Zlateva G, Mardekian J. Identifying fibromyalgia-associated symptoms and conditions from a clinical perspective: a step toward evaluating healthcare resource utilization in fibromyalgia. Pain Pract. 2010; 10:520–9. DOI:
10.1111/j.1533-2500.2010.00383.x. PMID:
20492578.

23. Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A, Fusaro E, et al. Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res (Hoboken). 2015; 67:143–50. DOI:
10.1002/acr.22403. PMID:
25047247.

24. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013; 18:119–26. DOI:
10.1155/2013/918216. PMID:
23748251. PMCID:
3673928.

25. Ghav idel-Parsa B, Amir Maafi A, Aarabi Y, Haghdoost A, Khojamli M, Montazeri A, et al. Correlation of invalidation with symptom severity and health status in fibromyalgia. Rheumatology (Oxford). 2015; 54:482–6. DOI:
10.1093/rheumatology/keu355. PMID:
25205826.
